Novonesis (Novozymes) B/ DK0060336014 /
08.05.2024 16:59:45 | Diff. - | Volumen | Geld16:59:45 | Brief16:59:45 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
417,40DKK | - | 172.762 Umsatz: 44,36 Mio. |
-Geld Vol: - | -Brief Vol: - | 116,62 Mrd.DKK | 1,43% | 31,48 |
GlobeNewswire
08:00
Caledonia Mining Corporation Plc Results for the Quarter ended March 31, 2024; Notice of Management ...
GlobeNewswire
08:00
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire
08:00
MC2 Therapeutics Receives Positive Feedback from FDA pre-IND Meeting and Updates on Indication Expan...
GlobeNewswire
07:01
Norsk Hydro: New Hydro CEO accelerating growth, value creation and sustainability to change the game...
GlobeNewswire
07:00
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chroni...
GlobeNewswire
07:00
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya...
GlobeNewswire
06:00
New Zealand’s 2degrees chooses Nokia 5G core software solutions running on Red Hat OpenShift
Newsfile Corp
05:55
Maxim88 Brings Salon Prive Table to the Online Casino Scene with Evolution Gaming
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite